medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2022, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2022; 38 (1)

Morbidity and mortality of 599 sickle cell disease patients in the Institute of Hematology and Immunology

Machín GSA, Svarch GE, Agramonte LOM, Menéndez VA, Lam DRM

Language: Spanish
References: 49
Page: 1-20
PDF size: 428.61 Kb.


ABSTRACT

Introduction: Sickle cell disease is the most common congenital hemolytic anemia in the world. Between 5 to 15% of the world population is a carrier of hemoglobin S and in Cuba, the frequency is 3.08%, which represents a public health problem.
Objective: To characterize the clinical picture, the hematological profile, and the probability of survival of patients with sickle cell disease at the Institute of Hematology and Immunology.
Method: A descriptive, longitudinal and retrospective study was carried out, which included all patients followed up for at least two years at the institution between January 1973 and December 2009.
Results: 599 patients (285 male), 439 SS/Sβ0tal and 160 SC/Sβ+tal, were included. The mean follow-up was 17.6±9.5 years. Patients between 20 and 59 years old predominated. The most frequent clinical events were painful vasocclusive crises, infections, acute chest syndrome, and liver complications. The reticulocytes, platelets, leukocytes and fetal hemoglobin values ​​were significantly higher in the SS/Sβ0tal patients, but not the total hemoglobin, which was higher in the SC/Sβ+tal. The overall survival probability of patients at 45 years was 70%. Stroke (17.5%), liver complications (17.5%), and cardiac complications (14.28%) were the main causes of death.
Conclusions: The demographic distribution and by hemoglobinopathies, the clinical events, and the hematological profile were similar to those found in patients from other geographic regions, except the frequency of liver complications, which was higher. The probability of survival was comparable with the best care centers in the world.


REFERENCES

  1. Piel FB, Steinberg MH, Rees DC. Sickle Cell Disease. N Engl J Med. 2017;376:1561-73. DOI: https://10.1056/NEJMra1510865

  2. Saraf Sl, Malokie RE, Nouraie M, Sable CA, Luchtman-Jones L, Ensing GL, et al. Differences in the clinical and genotypic presentation of sickle cell disease around the world. Pediatric Respire Rev. 2014 Mar;15(1):4-12. DOI: https://10.1016/j.prrv.2013.11.003

  3. Mburu J, Odame I. Sickle cell disease: Reducing the global disease burden. Int J Lab Hematol. 2019 May;41(Suppl 1):82-8. DOI: https://10.1111/ijlh.13023

  4. Colombo B, Martinez G. Haemoglobin variants in Cuba. Haemoglobin. 1985;(9):415-22.

  5. 5 Dean E. Sickle cell disease. Nurs Stand. 2016 Aug;30(49):17. DOI: https://10.7748/ns.30.49.17.s20

  6. Lentz MB, Kautz DD. Acute vaso-occlusive crisis in patients with sickle cell disease. Nursing. 2017 Jan ;47(1):67-8. DOI: https://10.1097/01.NURSE.0000510745.32219.dd

  7. Pincez T, Calamy L, Germont Z, Lemoine A, Lopes AA, Massiot A, et al. Pulmonary complications of sickle cell disease in children. Arch Pediatr. Oct 23 2016;(10):1094-106. DOI: https://10.1016/j.arcped.2016.06.014

  8. De Baun MR, Kirkham FJ. Central nervous system complications and management in sickle cell disease. Blood. Feb 2016;127(7):829-38. DOI: https://10.1182/blood-2015-09-618579

  9. Oligbu G, Fallaha M, Pay L, Ladhani S. Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature. Br J Haematol. May 2019;185(4):743-51. DOI: https://10.1111/bjh.15846

  10. Shah R, Taborda C, Chawla S. Acute and chronic hepatobiliary manifestations of sickle cell disease: A review. WJGP. Aug 8 2017(3):108-16. DOI: https://10.4291/wjgp.v8.i3.108

  11. AlDallal SM. Minireview: leg ulcers - a secondary complication of sickle cell disease. Int J Gen Med. 2019 Aug;12:279-82. DOI: https://10.2147/IJGM.S217369

  12. Bender MA. Sickle Cell Disease. Sep 15 2003 [Updated 17/08/2017]. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. Gene Reviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. [acceso 21/11/2019].Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK1377/

  13. Vanderhave KL, Perkins CA, Scannell B, Brighton BK. Orthopaedic Manifestations of Sickle Cell Disease. J Am Acad Orthop Surg. Feb26 2018(3):94-101. DOI: https://10.5435/JAAOS-D-16-00255

  14. Arduini GAO, Trovó de Marqui AB. Prevalence and Characteristics of Priapism in Sickle Cell Disease. Hemoglobin. Mar 2018;42(2):73-7. DOI: https://10.1080/03630269.2018.1452760

  15. Hariri E, Mansour A, El Alam A, Daaboul Y, Korjian S, AounBahous S. Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment. Int Urol Nephrol. Jun 2018;50(6):1075-83. DOI: https://10.1007/s11255-018-1803-3

  16. Machín García S, Guerra Alfonso T, Svarch E, Espinosa Martínez E, Mesa Cuervo J R, Dorticós Balea E, et al. Morbiletalidad en pacientes adultos con drepanocitosis. Rev Cubana Hematol Inmunol Hemoter [Internet] Ago 2004 [acceso 21/11/2019];20(2). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892004000200004&lng=es

  17. Platt OS, Brambilla BJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. Jun 1994; 330(23):1639-44.

  18. Kleihauer E, Braun H, Betke K. Demonstration of fetal hemoglobin in erythrocytes of a blood smear. KlinWochenschr. Jun 1957;35(12):637-8.

  19. Rodríguez F. Tinción de reticulocitos. Blog de Laboratorio clínico y biomédico. 21/06/2017. [acceso 10/04/2020]. Disponible en: Disponible en: https://www.franrzmn.com/tincion-de-reticulocitos/

  20. Datosmacro.com. Cuba. [acceso 01/06/2021]. Disponible en: Disponible en: https://datosmacro.expansion.com/demografia/poblacion/cuba

  21. Hamideh D, Alvarez O. Sickle cell disease related mortality in the United States (1999-2009). Pediatr Blood Cancer. Sep 2013;60(9):1482-6.

  22. Aloni MN, Kadima BT, Ekulu PM, Budiongo AN, Ngiyulu RM, Gini-Ehungu JL. Acute Crises and Complications of Sickle Cell Anemia Among Patients Attending a Pediatric Tertiary Unit in Kinshasa, Democratic Republic Of Congo. Hematol Rep. Jun 9 2017;(2):6952. DOI: https://10.4081/hr.2017.6952

  23. Serjeant GR, Vichinsky E. Variability of homozygous sickle cell disease: The role of alpha and beta globin chain variation and other factors. Blood Cells Mol Dis. May 2018;70:66-77. DOI: https://10.1016/j.bcmd.2017.06.004

  24. Asnani MR, Knight Madden J, Reid M, Greene LG, Lyew-Ayee P. Socio-environmental exposures and health outcomes among persons with sickle cell disease. PLoS One. Apr 2017;12(4):e0175260. DOI: https://10.1371/journal.pone.0175260

  25. Aleluia MM, Fonseca TCC, Souza RQ, Neves FI, da Guarda CC, Santiago RP, et al. Comparative study of sickle cell anemia and hemoglobin SC disease: clinical characterization, laboratory biomarkers and genetic profiles. BMC Hematol. Sep 2017;17:15. DOI: https://10.1186/s12878-017-0087-7

  26. Gualandro SF, Fonseca GH, Yokomizo IK, Gualandro DM, Suganuma LM. Cohort study of adult patients with haemoglobin SC disease: clinical characteristics and predictors of mortality. Br J Haematol. 2015 Nov;171(4):631-7. DOI: https://10.1111/bjh.13625

  27. Heeney MM, Ware RE. Sickle cell disease. In: Orkin SH, Fisher DE, Ginsburg D, Look T, Lux SE, Nathan DG. Nathan and Oski(s. Hematology and Oncology of Infancy and Childhood. 8th ed. Philadelphia: Elsevier Saunders; 2015. p. 675.

  28. Natrajan K, Kutlar A. Disorders of hemoglobin structure: Sickle cell anemia and related abnormalities in: Kaushansky K, Prchal JT, Press OW, Lichtman MA, M Levi, Burns LJ, et al. Williams Hematology. 9th ed. New York: McGraw-Hill Education; 2016. p. 762.

  29. El Hoss S, Brousse V. Considering the spleen in sickle cell disease. Expert Rev Hematol. 2019 Jul;12(7):563-73. DOI: https://10.1080/17474086.2019.1627192

  30. Serjeant GR. The Natural History of Sickle Cell Disease. Cold Spring Harb Perspect Med. 2013;3:a011783. DOI: https://10.1101/cshperspect.a011783

  31. Farooq S, Abu Omar M, Salzman GA. Acute chest syndrome in sickle cell disease. Hosp Pract. 2018 Aug;46(3):144-51. DOI: https://10.1080/21548331.2018.1464363

  32. Gardner K, Douiri A, Drasar E, Allman M, Mwirigi A, Awogbade M, et al. Survival in adults with sickle cell disease in a high-income setting. Blood. Sept 2016;128(10):1436-8. DOI: https://10.1182/blood-2016-05-716910

  33. Leyva Rodríguez A, Guerreiro Hernández AM, Merlin Linares JC, Villaescusa Blanco R, Arce Hernández AA. Hepatitis C en pacientes con drepanocitosis. Rev Cubana Hematol Inmunol Hemoter [revista en Internet]. 2014 [acceso 07/12/2019];31(1):[aprox. 0 p.]. Disponible en: Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/247

  34. Kissou SA, Koura M, Sawadogo A, Ouédraogo A, Traoré H, Kamboulé E, et al. Serological markers of viral hepatitis B and C in children with sickle cell disease monitored in the Pediatrics Department at the University Hospital of Bobo-Dioulasso (Burkina Faso). Bull Soc Pathol Exot. Aug 2017;110(3):160-4. DOI: https://10.1007/s13149-017-0555-4

  35. Blatyta PF, Kelly S, Sabino E, Preiss L, Mendes F, Carneiro-Proietti AB, et al. Prevalence of serologic markers of transfusion and sexually transmitted infections and their correlation with clinical features in a large cohort of Brazilian patients with sickle cell disease. Transfusion. Feb 2020;60(2):343-50. DOI: https://10.1111/trf.15619

  36. Alkindi S, Al-Umairi N, Jaju S, Pathare A. Prevalence of Hepatitis B, Hepatitis C, and HIV in Multiply Transfused Sickle Cell Disease Patients from Oman. Mediterr J Hematol Infect Dis. Nov 2019;11(1):e2019058. DOI: https://10.4084/MJHID.2019.058

  37. Theocharidou E, Suddle AR. The Liver in Sickle Cell Disease. Clin Liver Dis. May 2019;23(2):177-89. DOI: https://10.1016/j.cld.2018.12.002

  38. Espinosa Martínez E, Svarch Guerchicoff E, Martínez Antuña G, Hernández Ramírez P. La anemia drepanocítica en Cuba. Rev Cubana Hematol Inmunol Hemoter. 1996;12(2):97-105.

  39. dos Santos Brito Silva Furtado M, Viana MB, HicksonRrios JS, Gontijo RL, Silva CM, do Val Rezende P, et al. Prevalence and incidence of erythrovirus B19 infection in children with sickle cell disease: The impact of viral infection in acute clinical events. J Med Virol. Apr 2016;88(4):588-95. DOI: https://10.1002/jmv.24378

  40. Noubiap JJ, Mengnjo MK, Nicastro N, Kamtchum-Tatuene J. Neurologic complications of sickle cell disease in Africa: A systematic review and meta-analysis. Neurology. Oct 3 2017;89(14):1516-24. DOI: https://10.1212/WNL.0000000000004537

  41. Vichinsky E. Chronic organ failure in adult sickle cell disease. Hematology Am Soc Hematol Educ Program. Dec 2017;2017(1):435-9. DOI: https://10.1182/asheducation-2017.1.435

  42. Fasano RM, Miller MJ, Chonat S, Stowell SR. Clinical Presentation of Delayed Hemolytic Transfusion Reactions and Hyperhemolysis in Sickle Cell Disease. Transfus Clin Biol. May 2019;26(2);94-8. DOI: https://10.1016/j.tracli.2019.02.002

  43. Macharia AW, Mochamah G, Uyoga S, Ndila CM, Nyutu G, Makale J. The clinical epidemiology of sickle cell anemia in Africa. Am J Hematol. Mar 2018;93(3):363-70. DOI: https://10.1002/ajh.24986

  44. Hulihan M, Hassell KL, Raphael JL, Smith-Whitley K, Thorpe P. CDC Grand Rounds: Improving the Lives of Persons with Sickle Cell Disease. MMWR. Nov 2017;66(46):1269-71. DOI: https://10.15585/mmwr.mm6646a2

  45. Arduini GA, Rodrigues LP, Trovó de Marqui AB. Mortality by sickle cell disease in Brazil. Rev Bras Hematol Hemoter. Jan-Mar 2017;39(1):52-6. DOI: https://10.1016/j.bjhh.2016.09.008

  46. Serjeant GR, Chin N, Asnani MR, Serjeant BE, Mason KP, Hambleton IR, et al. Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth. PLoS One. Mar 13 2018(3):e0192710. DOI: https://10.1371/journal.pone.0192710

  47. Suárez Beyríes LC, Vargas Vega M, Simón Boada TI, Macías Navarro MM, Carmenaty Pérez A. Principales causas de muerte en adultos con hemoglobinopatías. MEDISAN. 2016;20(2):168-75.

  48. Jitraruch S, Fitzpatrick E, Deheragoda M, Deganello A, Mieli-Vergani G, Height S. Autoimmune Liver Disease in Children with Sickle Cell Disease. J Pediatr. Oct 2017;189:79-85. e2. DOI: https://10.1016/j.jpeds.2017.06.035

  49. Terziroli Beretta-Piccoli B., Mieli-Vergani G,Vergani D Autoimmune hepatitis. Nat Rev Dis Primers. Apr 2018;4:18018. DOI: https://10.1038/nrdp.2018.18




2020     |     www.medigraphic.com